ARCHIVES

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

This article is from The Cancer Letter archive.

Vol. 35 No. 28 | July 17, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: House Appropriations Subcommitee Plans Hearing On NCI March 24; New DTP Director Sought

February 25, 1983

In Brief: Eppley Is The “New” Center Getting an NCI Core; USC Appoints Jones Basic Science Chief

May 4, 1984

DCPC Board Defers Two Concepts More Approvals Listed

October 19, 1984

NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

February 21, 2014

Congress Plans to Accelerate Development of Drugs, Devices

December 19, 2014

FASEB Urges Congress To Fund Stem Cell Research.

July 27, 2001